Showing results (51-60 of 122) with videos related to

Sort By:
Pageof 13
Cancer Biology & Therapy|November 1, 2005
Avoiding glucocorticoid administration in a neurooncological caseHans Peter Rutz, Silvia Hofer, Pietro E Peghini, et al.
Cancer Letters|December 13, 2016
microRNA-210 overexpression inhibits tumor growth and potentially reverses gemcitabine resistance in pancreatic cancerPrince Saforo Amponsah, Pei Fan, Nathalie Bauer, et al.
International Journal of Cancer|January 22, 2015
Engineered adenoviruses combine enhanced oncolysis with improved virus production by mesenchymal stromal carrier cellsKatharina Hammer, Adam Kazcorowski, Li Liu, et al.
Experimental Cell Research|December 17, 2008
Suitability of human mesenchymal stem cells for gene therapy depends on the expansion mediumAnja Apel, Ariane Groth, Sabine Schlesinger, et al.
Haematologica|May 15, 2003
Natural killer resistance of a drug-resistant leukemia cell line, mediated by up-regulation of HLA class I expressionCarl Friedrich Classen, Christine S Falk, Claudia Friesen, et al.
Oncotarget|August 14, 2016
Up-regulation of microRNA let-7c by quercetin inhibits pancreatic cancer progression by activation of NumblClifford C Nwaeburu, Natalie Bauer, Zhefu Zhao, et al.
International Journal of Radiation Oncology, Biology, Physics|December 11, 2007
Postoperative spot-scanning proton radiation therapy for chordoma and chondrosarcoma in children and adolescents: initial experience at paul scherrer instituteHans Peter Rutz, Damien C Weber, Gudrun Goitein, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 3, 2004
Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomasDamien C Weber, Antony J Lomax, Hans Peter Rutz, et al.
International Journal of Cancer|December 30, 2003
Rescue of death receptor and mitochondrial apoptosis signaling in resistant human NSCLC in vivoStella Okouoyo, Kerstin Herzer, Esat Ucur, et al.
International Journal of Oncology|March 15, 2014
Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cellsSabrina Labsch, Li Liu, Nathalie Bauer, et al.
Pageof 13